4th Quarter - Report

POLSINELLI PC for AMERICAN SOCIETY FOR HISTOCOMPATIBILITY & IMMUNOGENETICS

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 2063, Organ Procurement Optimization Act VALID Act, Verifying Accurate, Leading-edge IVCT Development Act

LobbyistCovered position, as disclosed
TIMOTHY CASEY —
JAMES FOSTER FLEISCHMANN —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2063 (116th)

Medicare/Medicaid MMM

- The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 5534) - Issues impacting lab regulations and reimbursement - The Laboratory Access for Beneficiaries (LAB) Act (H.R. 3584) - Issues related to kidney health and kidney transplant access - Executive Order 13879 - Advancing American Kidney Health

LobbyistCovered position, as disclosed
TIMOTHY CASEY —
JAMES FOSTER FLEISCHMANN —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 5534 (116th), H.R. 3584 (116th)

Budget/Appropriations BUD

H.R. 2740 - Departments of Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 H.R. 1865, Further Consolidated Appropriations Act, 2020 [P.L. 116-94]

LobbyistCovered position, as disclosed
TIMOTHY CASEY —
JAMES FOSTER FLEISCHMANN —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 1865 (116th), H.R. 2740 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.